Relmada Therapeutics Inc
Ownership
Ownership Structure
Who owns Relmada Therapeutics Inc (RLMD)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 72.9% of the shares are freely tradable; institutional investors hold 93.1%.
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| HHG PLC | 10.37 | 11,063,862 | +52.2 | 03/31/2026 |
| Squadron Capital Management LLC | 6.89 | 7,350,000 | -13.3 | 06/30/2026 |
| Spruce Street Capital LP | 5.99 | 6,391,328 | +2.1 | 06/30/2026 |
| VR Adviser, LLC | 4.54 | 4,843,380 | +0.0 | 03/31/2026 |
| Adage Capital Partners Gp LLC | 4.47 | 4,763,158 | +0.0 | 06/30/2026 |
| Orbimed Advisors LLC | 4.42 | 4,715,864 | +80.6 | 03/31/2026 |
| Marshall Wace Asset Management Ltd | 4.20 | 4,481,606 | +40.5 | 03/31/2026 |
| Jones Hill Capital LP | 3.43 | 3,655,075 | +966.4 | 06/30/2026 |
| Vanguard Capital Management, LLC | 2.88 | 3,076,570 | +0.0 | 03/31/2026 |
Funds
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Vanguard MStar Total Stk Mkt Idx Invest | 2.97 | 3,169,804 | +0.0 | 08/31/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Insider holdings
| Person | Role | Shares | Value | As of | Type |
|---|---|---|---|---|---|
| Traversa Sergio | Chief Executive Officer | 1,500,000 | 5,700,000 $ | Sep 10, 2026 | direct |
| Shenouda Maged | Chief Financial Officer | 1,000,000 | 3,800,000 $ | Sep 10, 2026 | direct |
Holdings as of each person's most recent SEC Form 4 filing — excluding options and RSUs, which are not shares yet. Holdings may have changed between two filings.
Insiders
Insider Transactions
| Date | Person | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Sep 10, 2026 | Shenouda Maged | Chief Financial Officer | Buy | 79,800 | 4.25 | 339,150 |
| Sep 10, 2026 | Traversa Sergio | Chief Executive Officer | Buy | 100,000 | 4.10 | 410,000 |
| Sep 9, 2026 | Shenouda Maged | Chief Financial Officer | Buy | 120,200 | 4.20 | 504,840 |
| Sep 9, 2026 | Traversa Sergio | Chief Executive Officer | Buy | 100,000 | 4.18 | 418,000 |
Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character. View all insider transactions →
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.